ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Adma Biologics (ADMA)

Technical Analysis Report for NASDAQ stock ADMA Adma Biologics. Dated: 27 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ADMA Adma Biologics then click here. or read Experts views on Adma Biologics or Forecast & share price targets of Adma Biologics

Adma Biologics Opened at 11.02 and Closed at: 11.17, which is 0.9% of previous session's close. It moved within a range of 10.90 and 11.19
The session was a Bullish session with an average volume of 2219100, which is 8.65% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 11.04 and resistance for tomorrow is 11.33
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 10.98, 10.8 resistance for tomorrow's hourly charts is 11.27, 11.38

10 Day SMA for Adma Biologics (ADMA) is 10.89 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Adma Biologics (ADMA) is 10.51 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Adma Biologics (ADMA) is 9.9 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 9.36 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Adma Biologics is 10.98 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Adma Biologics is at 10.51 and 200 DMA is at 10.98, while 50 DMA and 100 DMA are at 9.9 and 9.36 respectively

Adma Biologics (ADMA) moving average of 20 SMA is at 10.51 and 20 EMA is at 10.56

Date Closing Price 20 SMA 20 EMA
27 Tue Oct 11.17 10.51 10.56
26 Mon Oct 11.07 10.45 10.5
23 Fri Oct 10.68 10.4 10.44
22 Thu Oct 10.95 10.34 10.41
21 Wed Oct 11.01 10.27 10.35
20 Tue Oct 11.23 10.2 10.28

Adma Biologics (ADMA) moving average of 50 SMA is at 9.9 and 50 EMA is at 10.05

Date Closing Price 50 SMA 50 EMA
27 Tue Oct 11.17 9.9 10.05
26 Mon Oct 11.07 9.86 10
23 Fri Oct 10.68 9.83 9.96
22 Thu Oct 10.95 9.8 9.93
21 Wed Oct 11.01 9.78 9.89
20 Tue Oct 11.23 9.76 9.84

Adma Biologics (ADMA) moving average of 100 SMA is at 9.36 and 100 EMA is at 10.03

Date Closing Price 100 SMA 100 EMA
27 Tue Oct 11.17 9.36 10.03
26 Mon Oct 11.07 9.33 10.01
23 Fri Oct 10.68 9.3 9.99
22 Thu Oct 10.95 9.27 9.98
21 Wed Oct 11.01 9.23 9.96
20 Tue Oct 11.23 9.2 9.94

Adma Biologics (ADMA) moving average of 200 SMA is at 10.98 and 200 EMA is at 11.21

Date Closing Price 200 SMA 200 EMA
27 Tue Oct 11.17 10.98 11.21
26 Mon Oct 11.07 11.01 11.21
23 Fri Oct 10.68 11.04 11.21
22 Thu Oct 10.95 11.08 11.22
21 Wed Oct 11.01 11.11 11.22
20 Tue Oct 11.23 11.15 11.22
Related Company CMP Open More...
Sanofi 41.89 41.55 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Arbutus Biopharma 4.29 4.20 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Zai Lab 23.58 23.10 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Co Diagnostics 0.47 0.59 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Insulet Corporation 149.83 148.07 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Axsome Therapeutics 142.20 143.99 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction
Alnylam Pharmaceuticals 226.79 225.00 Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa AI prediction

Adma Biologics has performed better than Arbutus Biopharma in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Alnylam Pharmaceuticals in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Axsome Therapeutics in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Co Diagnostics in short term. Holding Adma Biologics could be a better choice for now!

Insulet Corporation has performed better than Adma Biologics in short term. You could have earned much better returns by investing in Insulet Corporation, about 3.47% more returns!

Adma Biologics has performed better than Sanofi in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics has performed better than Zai Lab in short term. Holding Adma Biologics could be a better choice for now!

Adma Biologics Technical analysis of indicators

Price action analysis of Adma Biologics (ADMA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Adma Biologics in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Adma Biologics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Adma Biologics in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Adma Biologics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 10.89 and Adma Biologics ADMA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Adma Biologics ADMA stock. Volume based technical analysis of Adma Biologics ADMA stock is negative.

Adma Biologics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Adma Biologics indicators chart

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ADMA Adma Biologics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ADMA Experts View which covers a lot of information including buying and selling signals

ADMA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Adma Biologics or View Candle Stick Charts here

Chart Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics [

Videos related to: Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Adma Biologics (ADMA) Technical (Analysis) Reports Adma Biologics [

 

Back to top